At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people with diabetes.
Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results